Ledger.Open graph →
SEC Form D · filed May 6, 2024

Cidara Therapeutics, Inc

Offering
$240.0M
Sold
$240.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Theodore R. Schroeder · San Diego, CADirectorDaniel D. Burgess · San Diego, CADirectorPaul Feldman · Boston, MADirectorKurt Graves · Boston, MADirectorCarin R. Canale-Theakston · San Diego, CADirectorLaura R. Tadvalkar, Ph.D · San Diego, CADirectorTaylor R. Sandison, M.D · San Diego, CAExecLeslie R. Tari, Ph.D · San Diego, CAExecPreetam R. Shah, Ph.D · San Diego, CAExecBonnie R. Bassler, Ph.D · San Diego, CADirectorJames R. Merson, Ph.D · San Diego, CADirectorRyan R. Spencer · San Diego, CADirectorShane R. Ward · San Diego, CAExecJeffrey Stein, Ph.D · San Diego, CAExec · DirectorIan Charles · FARMINGTON HILLS, MIDirectorThomas L. Croft · DARTMOUTH, Nova Scotia, CanadaDirectorCarin R. Canale-Theakston · San Diego, CADirectorLaura R. Tadvalkar, Ph.D · San Diego, CADirectorTaylor R. Sandison, M.D · San Diego, CAExecLeslie R. Tari, Ph.D · San Diego, CAExecPreetam R. Shah, Ph.D · San Diego, CAExecBonnie R. Bassler, Ph.D · San Diego, CADirectorJames R. Merson, Ph.D · San Diego, CADirectorRyan R. Spencer · San Diego, CADirectorShane R. Ward · San Diego, CAExecJeffrey Stein, Ph.D · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗